Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05264701
Other study ID # KA-20105
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 7, 2022
Est. completion date May 1, 2024

Study information

Verified date June 2024
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.


Description:

Cardiovascular diseases constitute one of the most critical health problems of today's society due to the loss of workforce, morbidity, mortality, and high hospital expenses. This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date May 1, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria: - Patients with coronary artery disease - Access to the online program - Volunteering to participate in the research - Having an iOS or Android operating system compatible phone Exclusion Criteria: - Having a musculoskeletal problem - Having uncontrolled hypertension - Having chronic heart failure (NYHA III-IV) - A history of acute coronary syndrome or surgical revascularization less than 12 months ago - More than 50% occlusion on the main coronary artery - Having arrhythmia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physiotherapist supervised exercise training
Exercise training for 12 weeks will be given by video talk accompanied by a physiotherapist.
Exercise training via phone app
Exercise training for 12 weeks will be given over the developed phone application.
Physical activity recommendations
The program will be consist of 12 weeks of physical activity recommendations.

Locations

Country Name City State
Turkey Hacettepe University Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exercise Capacity Exercise capacity will be evaluated using the incremental shuttle walk test. Baseline, after 12 weeks, after 24 weeks
Primary Participation Participation will be evaluated using the number of sessions attended. after 12 weeks
Secondary Maximal Effort Capacity Maximal effort capacity will be evaluated using a cardiovascular stress test. Baseline
Secondary Peripheral muscle strength Peripheral muscle strength will be evaluated using the dynamometer. Baseline, after 12 weeks, after 24 weeks
Secondary Endothelial function The endothelial function will be evaluated using echocardiography. After a resting baseline, Brachial artery diameter will be recorded, the cuff used in blood pressure measurement will be inflated 25-50 mmHg above the systolic blood pressure value and maintain that pressure for 5 min. The brachial artery diameter will be measured again after the cuff is deflated. Baseline, after 12 weeks, after 24 weeks
Secondary Healthy Living Habit Evaluation Healthy living habit evaluation will be evaluated using the Healthy Lifestyle Behaviors Scale-II. Baseline, after 12 weeks, after 24 weeks
Secondary Health-Related Quality of Life Health-Related Quality of Life will be evaluated using the Myocardial Infarction Dimensional Assessment Scale (MIDAS). Baseline, after 12 weeks, after 24 weeks
Secondary QoL Quality of life will be evaluated using the SF-36 Short Form. Baseline, after 12 weeks, after 24 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A